Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Is Guidewire Software (NYSE:GWRE) Gaining Market Strength Within the NYSE Composite Framework?
Technology Stocks

Is Guidewire Software (NYSE:GWRE) Gaining Market Strength Within the NYSE Composite Framework?

Highlights,Guidewire Software expands into Japan through a cloud migration partnership with Mitsui Direct,The company’s ClaimCenter is adopted on the Guidewire Cloud Platform, enhancing global reach,Guidewire has demonstrated consistent return performance...

Is IDEX Corporation (NYSE:IEX) the Next Name to Watch Among the Best Dividend Stocks?
Industrial Stocks

Is IDEX Corporation (NYSE:IEX) the Next Name to Watch Among the Best Dividend Stocks?

Highlights,IDEX announces a higher dividend than in the previous year, reflecting consistent growth,Dividend distributions remain well-covered by both earnings and cash flow,The company has a long history of stable, increasing payments over the years,Spec...

UK takeover panel gives Qualcomm till May 27 to make a bid for Alphawave
Market Updates

UK takeover panel gives Qualcomm till May 27 to make a bid for Alphawave

(Reuters) -British semiconductor company Alphawave IP Group on Monday said the UK takeover panel had extended the deadline for a takeover offer by U.S. chipmaker Qualcomm to May 27. The deadline to ma...

  • May 11, 2025 11:18 PM PDT
  • EODHD
Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) is an efficacious and well-tolerated long-acting growth hormone in children with growth disorders: results from REAL8 phase 3 basket study presented at the joint Congress of ESPE and ESE
Market Updates

Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) is an efficacious and well-tolerated long-acting growth hormone in children with growth disorders: results from REAL8 phase 3 basket study presented at the joint Congress of ESPE and ESE

Novo Nordisk A/S The REAL8 trial showed that after 52 weeks, once-weekly Sogroya® (somapacitan) had similar clinical outcomes and safety profile to once-daily Norditropin® (somatropin) in children bor...

  • May 11, 2025 11:01 PM PDT
  • EODHD
UniCredit Lifts Outlook After Earnings Beat Market Expectations
Market Updates

UniCredit Lifts Outlook After Earnings Beat Market Expectations

UniCredit lifted its guidance for the year after first-quarter earnings beat analysts’ expectations, boosted by higher fee income. The Italian lender said net profit increased to 2.77 billion euros ($...

  • May 11, 2025 10:53 PM PDT
  • EODHD
Trump Drug Plan Hits Asian Pharma Stocks
Market Updates

Trump Drug Plan Hits Asian Pharma Stocks

Shares of Asian drugmakers fell after President Trump said he would sign an executive order to lower the cost of prescription drugs. Shares of Japan's Daiichi Sankyo, which gets about a third of its r...

  • May 11, 2025 09:05 PM PDT
  • EODHD
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial
Market Updates

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

(Reuters) -Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial....

  • May 11, 2025 03:06 PM PDT
  • EODHD
Inflation Reports, Walmart, Cisco Earnings; and More to Watch This Week
Market Updates

Inflation Reports, Walmart, Cisco Earnings; and More to Watch This Week

Simon Property, Sony, Alibaba, and Deere will also report earnings. Economic releases this week will include data on inflation, producer prices, and retail sales. Continue Reading View Comments

  • May 11, 2025 11:00 AM PDT
  • EODHD
OpenAI and Microsoft renegotiate multibillion-dollar partnership terms - report
Market Updates

OpenAI and Microsoft renegotiate multibillion-dollar partnership terms - report

Investing.com -- OpenAI and Microsoft Corporation (NASDAQ:MSFT) are currently in discussions to revise the terms of their multibillion-dollar partnership, according to a Financial Times report on Sund...

  • May 11, 2025 10:12 AM PDT
  • EODHD
Prediction: This Artificial Intelligence (AI) Semiconductor Stock Will Soar After May 28
Market Updates

Prediction: This Artificial Intelligence (AI) Semiconductor Stock Will Soar After May 28

Most of the major players in the AI landscape have already delivered their Q1 earnings reports -- but Nvidia's results are still to come.

  • May 11, 2025 09:21 AM PDT
  • EODHD